Insider Transactions Reported by 22 Insiders of CRISPR Therapeutics AG

Symbol
CRSP on Nasdaq
Location
Zug

Insiders trading volume in the past year

CRISPR Therapeutics AG executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Simeon George Director $90,021,213 +$51,499,918 +134% 16 Jul 2025
Rodger Novak President, Director $35,814,599 30 Jun 2021
Samarth Kulkarni Chief Executive Officer, Director $15,835,053 -$7,549,528 -32% 18 Dec 2025
Bradley J. Bolzon PhD Director $9,302,369 09 Jun 2022
JAMES R. KASINGER General Counsel and Secretary $5,554,573 -$991,714 -15% 13 Oct 2025
Tony W. Ho Executive VP, Head of R&D $3,272,902 03 Dec 2021
Lawrence Otto Klein Cbo & Coo $1,674,890 16 Aug 2022
Douglas A. Treco Director $1,254,660 +$1,140,600 +1000% 06 Aug 2025
Julianne Bruno Chief Operating Officer $726,967 -$147,301 -17% 20 Mar 2025
Raju Prasad Chief Financial Officer $384,946 -$807,383 -68% 22 Dec 2025
Brendan Smith Chief Financial Officer $317,015 18 Feb 2023
John Greene Director $313,948 +$313,948 05 Jun 2025
Phuong Khanh Morrow Chief Medical Officer $275,700 13 Oct 2023
Naimish Patel Chief Medical Officer $218,083 -$141,316 -39% 03 Oct 2025
Briggs Morrison Director $195,806 05 Jun 2025
MICHAEL JOHN TOMSICEK Chief Financial Officer $118,193 06 Aug 2021
Sandesh Mahatme Director 05 Jun 2025
Harold Edward Fleming Director 05 Jun 2025
Ali Behbahani Director 05 Jun 2025
Maria Fardis Director 05 Jun 2025
Christian Rommel Director 05 Jun 2025
Katherine A. High Director 05 Jun 2025

Recent Insider Transactions by Companies or Individuals for CRISPR Therapeutics AG

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.